Search

Author/Creator Mori, Julie

2. Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials. (December 2019)

Authors:
Jubb, Becky; Lewis, Marilyn; McFadyen, Lynn; Simpson, Paul; Mori, Julie; Chan, Phylinda; Weatherley, Barry; van der Ryst, Elna; Westby, Mike; Craig, Charles
Journal:
Antiviral chemistry & chemotherapy
Issue:
Volume 27(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study. (20th November 2020)

Authors:
DeVincenzo, John; Cass, Lindsey; Murray, Alison; Woodward, Kathy; Meals, Elizabeth; Coates, Matthew; Daly, Leah; Wheeler, Vicky; Mori, Julie; Brindley, Charlie; Davis, Amanda; McCurdy, Meabh; Ito, Kazuhiro; Murray, Bryan; Strong, Pete; Rapeport, Garth
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 12(2022)
Page Start:
2087
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗